Nadolol Versus Propranolol in Children With Infantile Hemangiomas: a Randomized, Controlled, Double-blinded Trial
The purpose of this study is to assess the efficacy and safety of oral propranolol versus
nadolol in patients with Infantile Hemangiomas (IH) in a randomized, controlled,
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society